HMO-2FL

· DSM-Firmenich Switzerland AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HMO-2FL, covering 2026-03-11 to 2026-03-11. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating the Efficacy of Different Mixes of HMO-2FL + Humiome® Post LB on IBS Gastrointestinal Symptoms [NA]

See pricing